Invesaro

Stocks YUMC Financial statements

Financial statements

Yum China Holdings, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Yum China Holdings, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue7,0757,7698,4158,7768,2639,8539,56910,97811,30311,797
Cost of revenue5,6105,829
Gross profit1,4651,940
Research and development5544366668
General and administrative429495456487479564594638568581
Operating income6347789419019611,3866291,1061,1621,290
Pre-tax income6668039501,0031,1081,3926871,2261,3311,358
Income tax156379214260295369207329356369
Net income to minority interests12262830293336746975
Net income498398708713784990442827911929
EBITDA1,0361,1871,3861,3291,4111,9021,2311,5591,6381,738
EPS, basic1.351.031.841.892.012.341.051.992.342.52
EPS, diluted1.351.001.791.841.952.281.041.972.332.51
Shares, basic (weighted)368387384377390422421416388369
Shares, diluted (weighted)369398395388402434425420390371
Dividend per share0.100.420.480.240.480.480.520.640.96

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents8851,0591,2661,0461,1581,1361,1301,128723506
Short-term investments792051226113,1052,8602,0221,4721,121878
Receivables74798088996764687995
Inventory268297307380398432417424405438
Other current assets8160668711917611199107102
Total current assets1,4261,8021,9522,2594,9364,7163,9403,4312,6942,357
Property, plant and equipment1,6471,6911,6151,5941,7652,2512,1182,3102,4072,543
Lease right-of-use assets1,9852,1642,6122,2192,2172,1462,189
Goodwill791082662548322,1421,9881,9321,8801,963
Intangible assets8810111694246272159150144148
Other non-current assets254385491580749742248265256362
Total assets3,7274,2874,6106,95010,87513,22311,82612,03111,12110,783
Accounts payable480420619623708830727786801793
Accrued liabilities191219200223238283285299235261
Deferred revenue7296135175182182196196205
Short-term debt216812730
Total current liabilities1,0041,0241,2531,7362,0672,3832,1662,4222,2832,246
Lease liabilities1,8031,9152,2861,9061,8991,8161,823
Other non-current liabilities252388355210167167162157157158
Total liabilities1,2841,4401,6333,7754,4045,3014,6664,9124,6944,684
Paid-in capital2,3522,3752,4022,4274,6584,6954,3904,3204,0283,796
Retained earnings403979441,4162,1052,8922,1912,3102,0891,764
Treasury stock-20-148-460-721-728-803-52-28
Other comprehensive income1137-17-49167268-103-229-341-157
Shareholders' equity2,3772,7652,8733,0776,2067,0566,4826,4055,7285,379
Minority interests667710398253852666701686720
Total equity2,4432,8422,9763,1756,4597,9087,1487,1066,4146,099
Total liabilities and equity3,7274,2874,6106,95010,87513,22311,82612,03111,12110,783
Shares outstanding383385379376420428419407378354

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income5104247367438131,0234789019801,004
Depreciation and amortization402409445428450516602453476448
Stock-based compensation16262426364142644142
Deferred income tax-42623316111160-20-10-7-14
Change in receivables-541-13-9-15-5-1-6-9-11
Change in inventory-96-11-23-7717-16-19-198-14
Change in payables123-56254171651181684-3-33
Cash from operations8668841,3331,1851,1141,1311,4131,4731,4191,466
Capital expenditures-436-415-470-435-419-689-679-710-705-626
Acquisitions-25-91-288-115-23
Purchases of investments-136-596-74-1,024-4,499-6,139-5,189-3,517-4,728-7,583
Sales and maturities of investments6,3835,3653,4995,2518,216
Cash from investing-471-557-552-910-3,109-855-522-743-178-5
Stock issued52,195
Share buybacks-128-307-265-8-75-466-613-1,249-1,144
Dividends paid-38-161-181-95-203-202-216-248-353
Cash from financing93-185-518-4802,058-313-844-716-1,636-1,689
Exchange rate effect-2832-56
Net change in cash460174207-211103-22-6-2-405-217
Free cash flow430469863750695442734763714840
Interest paid34
Income taxes paid182232208255170255204324393370

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $40.47 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin11.1%Operating income / revenue.
EBITDA margin14.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin11.5%Pre-tax income / revenue.
Net margin7.8%Net income / revenue.
FCF margin7.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin12.7%Cash from operations / revenue.
Effective tax rate27.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)18.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)9.0%Net income / average total assets.
Return on invested capital (ROIC)20.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue5.1%Capital expenditures / revenue.
D&A / revenue3.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y4.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y7.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y7.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y11.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y27.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y6.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y6.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y12.2%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y4.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y2.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y28.1%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y3.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y7.7%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y34.1%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y5.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y3.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y1.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y5.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y17.6%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y4.6%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y3.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y50.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y26.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y32.0%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-6.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-6.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-2.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-3.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-3.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-0.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-4.9%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-4.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.96xCurrent assets / current liabilities.
Quick ratio0.62x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.57x(Cash + short-term investments) / current liabilities.
Liabilities / assets44.2%Total liabilities / total assets.
Working capital-$86.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets20.0%(Goodwill + intangible assets) / total assets.
Tangible book value$3.19BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.14xRevenue / average total assets.
Fixed asset turnover4.74xRevenue / average property, plant and equipment.
Receivables turnover108xRevenue / average receivables.
Days sales outstanding3 days365 x average receivables / revenue.
FCF conversion96.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow40.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.79Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$35.64Revenue / diluted weighted shares.
FCF per share$2.69Free cash flow / diluted weighted shares.
Operating cash flow per share$4.52Cash from operations / diluted weighted shares.
Book value per share$15.53Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$9.23Tangible book value / shares outstanding.
Cash per share$4.02(Cash + short-term investments) / shares outstanding.
Payout ratio38.6%Dividends paid / net income, when net income is positive.
Dividends / FCF40.0%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF138.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$13.86BShare price x shares outstanding.
Enterprise value$12.47BMarket cap + total debt - cash - short-term investments.
P/E14.2xMarket cap / net income. Only when net income is positive.
P/S1.11xMarket cap / revenue.
P/B2.59xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book4.35xMarket cap / tangible book value, when positive.
P/FCF14.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.78xMarket cap / cash from operations, when positive.
EV/Sales1.00xEnterprise value / revenue.
EV/EBIT9.03xEnterprise value / operating income, when both are positive.
EV/EBITDA6.75xEnterprise value / EBITDA, when both are positive.
EV/FCF13.3xEnterprise value / free cash flow, when both are positive.
FCF yield6.8%Free cash flow / market cap.
Earnings yield7.0%Net income / market cap (the inverse of P/E).
Dividend yield2.7%Dividends paid over the period / market cap.
Shareholder yield12.1%(Dividends paid + share buybacks) / market cap.
PEG0.42xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Yum China Holdings, Inc.'s revenue in fiscal 2025?

Yum China Holdings, Inc. reported revenue of $11.80B for fiscal 2025, 4.4% higher than the year before.

Was Yum China Holdings, Inc. profitable in fiscal 2025?

Yes. Net income was $929.0M, a net margin of 7.9%.

How much free cash flow did Yum China Holdings, Inc. generate in fiscal 2025?

Cash from operations of $1.47B minus capital expenditures of $626.0M left free cash flow of $840.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Yum China Holdings, Inc.